Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. bexarotene

   LIGAND PHARMACEUTICALS INC

   Cutaneous T-Cell Lymphoma

   phase 2 · small molecule · completed

   1 trial →

2. biricodar dicitrate

   Vertex Pharmaceuticals (Australia) Pty.

   Lung Cancer

   phase 2 · small molecule · terminated

   1 trial →

3. bleomycin sulfate

   Children's Hospital of Fudan University

   Childhood Germ Cell Tumor

   phase 2 · mab · completed

   1 trial →

4. cRGD-ZW800-1

   Disc Medicine

   Oral cancer

   phase 2 · small molecule · active

   1 trial →

5. cRGD-ZW800-1

   Disc Medicine

   Squamous cell carcinoma of the larynx and hypopharynx

   phase 2 · small molecule · active

   1 trial →

6. cadonilimab combined +paclitaxel (albumin-bound)

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Gastric Adenocarcinoma

   phase 2 · small molecule · active

   1 trial →

7. cadonilizumab combined with neoadjuvant radiochemotherapy

   The First People's Hospital of Lianyungang

   Esophageal Squamous Cell Carcinoma

   phase 2 · other · active

   1 trial →

8. capecitabine

   Cardiff Oncology

   Pancreatic Cancer

   phase 2 · small molecule · completed

   1 trial →

9. carboplatin

   Cardiff Oncology

   Bladder Cancer

   phase 2 · small molecule · completed

   1 trial →

10. cardonilizumab combined with renvastinib

    The First People's Hospital of Lianyungang

    Resectable Clear Cell Carcinoma of the Kidney

    phase 2 · small molecule · active

    1 trial →

11. cemacabtagene ansegedleucel

    Allogene Therapeutics

    Large B-cell Lymphoma

    phase 2 · gene therapy · active

    1 trial →

12. cemiplimab

    Regeneron UK Limited

    Carcinoma, Basal Cell

    phase 2 · small molecule · completed

    1 trial →

13. cemiplimab

    Regeneron UK Limited

    Melanoma

    phase 2 · small molecule · active

    1 trial →

14. cemiplimab

    Regeneron UK Limited

    Cutaneous Basal Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

15. cemiplimab

    Regeneron UK Limited

    Advanced Cutaneous Squamous Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

16. cemiplimab (monotherapy)

    Regeneron UK Limited

    Relapsed Solid Tumor

    phase 2 · small molecule · terminated

    1 trial →

17. certepetide

    LISATA THERAPEUTICS, INC.

    Pancreas Cancer

    phase 2 · small molecule · terminated

    1 trial →

18. certepetide

    LISATA THERAPEUTICS, INC.

    Cholangiocarcinoma

    phase 2 · small molecule · active

    1 trial →

19. cetrelimab, JNJ-63723283

    Janssen-Cilag International N.V.

    Advanced Stage Solid Tumors

    phase 2 · small molecule · active

    1 trial →

20. cetuximab (Erbitux)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 2 · small molecule · completed

    1 trial →

21. chemotherapy: TS-1, Leucovorin and Gemcitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Adenocarcinoma

    phase 2 · small molecule · completed

    1 trial →

22. chidamide + camrelizumab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

23. chidamide，fulvestrant

    The First People's Hospital of Lianyungang

    Hormone Receptor-positive Advanced Breast Cancer

    phase 2 · small molecule · active

    1 trial →

24. cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

25. cisplatin

    Cardiff Oncology

    Bladder Cancer

    phase 2 · small molecule · completed

    2 trials →

26. cisplatin and 5-Fu combined with nimotuzumab

    The First People's Hospital of Lianyungang

    Stage IV Nasopharyngeal Carcinoma

    phase 2 · small molecule · completed

    1 trial →

27. combination with Disitamab Vedotin and with Tislelizumab and Capecitabine

    Hospital Authority, Hong Kong

    Gastric Cancer

    phase 2 · small molecule · active

    1 trial →

28. cytarabine

    Teva Pharma GmbH

    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome

    phase 2 · small molecule · terminated

    1 trial →

29. delolimogene mupadenorepvec

    Chongqing Precision Biotech Co., Ltd

    Malignant Melanoma

    phase 2 · gene therapy · completed

    1 trial →

30. disitamab vedotin

    Pfizer

    Urothelial Carcinoma

    phase 2 · small molecule · active

    1 trial →

31. docetaxel

    Sanofi Pasteur

    Nasopharyngeal Neoplasms

    phase 2 · small molecule · completed

    1 trial →

32. docetaxel and ketoconazole

    Hospital Authority, Hong Kong

    Metastatic Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

33. docetaxel+CDDP

    Solid Biosciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

34. donor-derived NK cell infusion

    Chongqing Precision Biotech Co., Ltd

    Non-small Cell Lung Cancer

    phase 2 · mab · active

    1 trial →

35. doxorubicin, docetaxel

    Hospital Authority, Hong Kong

    Metastatic Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

36. entinostat

    Syndax Pharmaceuticals

    Breast Cancer

    phase 2 · small molecule · completed

    4 trials →

37. entinostat

    Syndax Pharmaceuticals

    Epithelial Ovarian Cancer

    phase 2 · small molecule · completed

    1 trial →

38. entinostat

    Syndax Pharmaceuticals

    Estrogen Receptor-negative Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

39. eribulin mesylate + erlotinib

    Eisai Co.,

    Non-small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

40. erlotinib [Tarceva]

    Hoffmann-La Roche

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

41. erlotinib and bexarotene

    LIGAND PHARMACEUTICALS INC

    Carcinoma, Non-small-cell Lung

    phase 2 · small molecule · completed

    1 trial →

42. everolimus

    United Therapeutics Europe Ltd

    Malignant Peripheral Nerve Sheath Tumors

    phase 2 · small molecule · completed

    1 trial →

43. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Head and Neck Cancer

    phase 2 · small molecule · active

    2 trials →

44. experimental group x-MAP

    The First People's Hospital of Lianyungang

    Metastatic Colorectal Cancer (mCRC)

    phase 2 · other · active

    1 trial →

45. farletuzumab ecteribulin

    Bristol-Myers Squibb Australia Pty Ltd

    Metastatic Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

46. forodesine HCl

    Biocryst

    Chronic Lymphocytic Leukemia (CLL)

    phase 2 · small molecule · completed

    1 trial →

47. forodesine hydrochloride

    Biocryst

    Lymphoma

    phase 2 · small molecule · completed

    2 trials →

48. forodesine hydrochloride (BCX-1777)

    Biocryst

    Leukemia, Lymphocytic, Chronic

    phase 2 · small molecule · completed

    1 trial →

Frequently asked questions